2025年6月7日 周六
Home > Archive>Volume 31, Issue 8, 2023 >731-736
PDF HTML XML Export Cite reminder
Research progress on the role of irisin in glycolipid metabolism related diseases
Author:
Affiliation:

Department of Endocrinology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei 067000, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference [40]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Irisin is mainly a muscle cytokine produced and secreted by muscle cells after exercise, and is also expressed in the adipose tissue, liver, pancreas, testes, stomach, and other tissues. Irisin is derived from the fibronectin type Ⅲ domain containing 5 (FNDC5) through its extracellular fragment proteolytic cleavage and secreted in the peripheral circulation. Irisin converts white adipose tissue into brown adipose tissue, increases mitochondrial metabolism and energy expenditure, ameliorates insulin resistanc, differentiates neural and proliferates osteoblasts through signaling pathways such as MAPK, AMPK, PI3K/Akt and STAT3/Snail. And it is expected to become a new target for the treatment of glycolipid metabolism related diseases.

    Reference
    [1] SHEN S N, LIAO Q W, CHEN X P, et al.The role of irisin in metabolic flexibility:beyond adipose tissue browning.Drug Discov Today, 2,7(8):2261-2267.
    [2] BOSTRM P, WU J, JEDRYCHOWSKI M P, et al.A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.Nature, 2,1(7382):463-468.
    [3] MAAK S, NORHEIM F, DREVON C A, et al.Progress and challenges in the biology of FNDC5 and irisin.Endocr Rev, 1,2(4):436-456.
    [4] KORTA P, POCHEC＇ E, MAZUR-BIAY A.Irisin as a multifunctional protein:implications for health and certain diseases.Medicina (Kaunas), 9,5(8):485.
    [5] WASEEM R, SHAMSI A, MOHAMMAD T, et al.Multispectroscopic and molecular docking insight into elucidating the interaction of irisin with rivastigmine tartrate:a combinational therapy approach to fight Alzheimers disease.ACS Omega, 1,6(11):7910-7921.
    [6] MA C L, DING H C, DENG Y T, et al.Irisin:a new code uncover the relationship of skeletal muscle and cardiovascular health during exercise.Front Physiol, 1,2:620608.
    [7] COLAIANNI G, ERREDE M, SANESI L, et al.Irisin correlates positively with BMD in a cohort of older adult patients and downregulates the senescent marker p21 in osteoblasts.J Bone Miner Res, 1,6(2):305-314.
    [8] COLAIANNI G, STORLINO G, SANESI L, et al.Myokines and osteokines in the pathogenesis of muscle and bone diseases.Curr Osteoporos Rep, 0,8(4):401-407.
    [9] YOUNG M F, VALARIS S, WRANN C D.A role for FNDC5/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases.Prog Cardiovasc Dis, 9,2(2):172-178.
    [10] RABIEE F, LACHINANI L, GHAEDI S, et al.New insights into the cellular activities of Fndc5/Irisin and its signaling pathways.Cell Biosci, 0,0(1):51.
    [11] LIU J Y, SONG N N, HUANG Y B, et al.Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway.Sci Rep, 8,8(1):15247.
    [12] MA E B, SAHAR N E, JEONG M, et al.Irisin exerts inhibitory effect on adipogenesis through regulation of Wnt signaling.Front Physiol, 9,0:1085.
    [13] ZHENG S, CHEN N X, KANG X J, et al.Irisin alleviates FFA induced β-cell insulin resistance and inflammatory response through activating PI3K/AKT/FOXO1 signaling pathway.Endocrine, 2,5(3):740-751.
    [14] ARHIRE L I, MIHALACHE L, COVASA M.Irisin:a hope in understanding and managing obesity and metabolic syndrome.Front Endocrinol (Lausanne), 9,0:524.
    [15] LI J, YI X, LI T, et al.Effects of exercise and dietary intervention on muscle, adipose tissue, and blood IRISIN levels in obese male mice and their relationship with the beigeization of white adipose tissue.Endocr Connect, 2,1(3):e210625.
    [16] LUO Y, QIAO X, MA Y, et al.Disordered metabolism in mice lacking irisin.Sci Rep, 0,0(1):17368.
    [17] CHEN Y, ZHAO Y F, JIANG Y, et al.Effects of irisin on lipid in mice and glycolipid metabolism in obese mice induced by diet.Chin Med Abstracts(Int Med), 1,8(3):150-151.
    [18] LIU S, DU F, LI X, et al.Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells.PLoS One, 7,2(4):e0175498.
    [19] NATALICCHIO A, MARRANO N, BIONDI G, et al.The myokine irisin is released in response to saturated fatty acids and promotes pancreatic β-cell survival and insulin secretion.Diabetes, 7,6(11):2849-2856.
    [20] YANO N, ZHANG L, WEI D, et al.Irisin counteracts high glucose and fatty acid-induced cytotoxicity by preserving the AMPK-insulin receptor signaling axis in C2C12 myoblasts.Am J Physiol Endocrinol Metab, 0,8(5):E791-E805.
    [21] XIONG Y, WU Z H, ZHANG B, et al.FNDC5 loss-of-function attenuates exercise-induced browning of white adipose tissue in mice.FASEB J, 9,3(5):5876-5886.
    [22] DAUDON M, RAM C, PRICE C, et al.Irisin modulates glucose metabolism and inhibits steroidogenesis in bovine granulosa cells.Reproduction, 3,5(5):533-542.
    [23] ZHANG M, XU Y, JIANG L.Irisin attenuates oxidized low-density lipoprotein impaired angiogenesis through AKT/mTOR/S6K1/Nrf2 pathway.J Cell Physiol, 9,4(10):18951-18962.
    [24] FU J, LI F, TANG Y, et al.The emerging role of irisin in cardiovascular diseases.J Am Heart Assoc, 1,0(20):e022453.
    [25] LI H, SHEN J, WU T, et al.Irisin is controlled by farnesoid X receptor and regulates cholesterol homeostasis.Front Pharmacol, 9,0:548.
    [26] CHEN K, ZHOU M, WANG X, et al.The role of myokines and adipokines in hypertension and hypertension-related complications.Hypertens Res, 9,2(10):1544-1551.
    [27] HASSAAN P S, NASSAR S Z, ISSA Y, et al.Irisin vs.treadmill exercise in post myocardial infarction cardiac rehabilitation in rats.Arch Med Res, 9,0(2):44-54.
    [28] ZHANG J, REN Y, BI J, et al.Involvement of kindlin-2 in irisins protection against ischaemia reperfusion-induced liver injury in high-fat diet-fed mice.J Cell Mol Med, 0,4(22):13081-13092.
    [29] LI X D, DUAN H K, LIU Q Q, et al.Construction of a pichia pastoris strain efficiently secreting irisin and assessment of its bioactivity in HepG2 cells.Int J Biol Macromol, 9,4:60-70.
    [30] LIAO X, ZHAN W, LI R, et al.Irisin ameliorates endoplasmic reticulum stress and liver fibrosis through inhibiting PERK-mediated destabilization of HNRNPA1 in hepatic stellate cells.Biol Chem, 1,2(6):703-715.
    [31] KATSAROU A, Moustakas I I, Pyrina I, et al.Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.World J Gastroenterol, 0,6(17):1993-2011.
    [32] ZHU W W, SAHAR N E, JAVAID H M A, et al.Exercise-induced irisin decreases inflammation and improves NAFLD by competitive binding with MD2.Cells, 1,0(12):3306.
    [33] LI Q, TAN Y, CHEN S N, et al.Irisin alleviates LPS-induced liver injury and inflammation through inhibition of NLRP3 inflammasome and NF-κB signaling.J Recept Signal Transduct Res, 1,1(3):294-303.
    [34] XU R Q, LIU Q, MA X X, et al.Irisin inhibits PCSK9 expression through activating AMPK-SREBP2 pathway.Biochem Biophys Res Commun, 2,0:77-83.
    [35] LI D J, SUN S J, FU J T, et al.NAD＋-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin.Theranostics, 1,1(9):4381-4402.
    [36] LI Q X, JIA S H, XU L, et al.Metformin-induced autophagy and irisin improves INS-1 cell function and survival in high-glucose environment via AMPK/SIRT1/PGC-1α signal pathway.Food Sci Nutr, 9,7(5):1695-1703.
    [37] SHEN S N, LIAO Q W, ZHANG T, et al.Myricanol modulates skeletal muscle-adipose tissue crosstalk to alleviate high-fat diet-induced obesity and insulin resistance.Br J Pharmacol, 9,6(20):3983-4001.
    [38] LI H, DONELAN W, WANG F, et al.GLP-1 induces the expression of FNDC5 derivatives that execute lipolytic actions.Front Cell Dev Biol, 1,9:777026.
    [39] GUO A, LI K, TIAN H C, et al.FGF19 protects skeletal muscle against obesity-induced muscle atrophy, metabolic derangement and abnormal irisin levels via the AMPK/SIRT-1/PGC-alpha pathway.J Cell Mol Med, 1,5(7):3585-3600.
    [40] LIU Y, XU F, JIANG P.Effect of sitagliptin on expression of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1α and irisin in a rat model of type 2 diabetes mellitus.J Int Med Res, 0,8(5):300060519885569.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

ZHAO Lihua, GAO Yu. Research progress on the role of irisin in glycolipid metabolism related diseases[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(8):731-736.

Copy
Share
Article Metrics
  • Abstract:331
  • PDF: 1353
  • HTML: 0
  • Cited by: 0
History
  • Received:September 30,2022
  • Revised:March 10,2023
  • Online: July 20,2023
Article QR Code

You are the 55860 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025